End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.06 USD | +0.33% | -0.49% | -12.17% |
03-19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-05 | Sipai Health Technology Expects to Narrow Loss in Full Year 2023 | MT |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.83 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.17% | 592M | - | ||
-30.37% | 15.68B | B- | ||
-20.59% | 12.39B | B | ||
-21.23% | 6.74B | B | ||
-6.15% | 6.29B | C+ | ||
+11.76% | 6.26B | C | ||
+70.00% | 4.95B | C | ||
-2.77% | 4.66B | D- | ||
-5.58% | 4.03B | B | ||
-7.87% | 3.62B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 314 Stock
- Ratings Sipai Health Technology Co., Ltd.